Search Results - "MEHARCHARD, Jacinta"

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial by STEWART, A. Keith, VESCIO, Robert, STIFF, Pat, MEHARCHARD, Jacinta, SCHLOSSMAN, Robert, BROWN, Randy, TULLY, Heather, BENYUNES, Mark, JACOBS, Cindy, BERENSON, Ronald, WHITE, Michael, DIPERSIO, John, SCHILLER, Gary, ANDERSON, Kenneth C, BERENSON, James, BALLESTER, Oscar, NOGA, Stephen, RUGO, Hope, FREYTES, Cesar, STADTMAUER, Edward, TARANTOLO, Stefano, SAHEBI, Firoozeh

“…Although high-dose chemotherapy supported by autologous peripheral-blood progenitor-cell (PBPC) transplantation improves response rates and survival for…”
Get full text

Multicenter Phase III Trial to Evaluate CD34+ Selected Versus Unselected Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma by Vescio, Robert, Schiller, Gary, Stewart, A. Keith, Ballester, Oscar, Noga, Stephen, Rugo, Hope, Freytes, Cesar, Stadtmauer, Edward, Tarantolo, Stefano, Sahebi, Firoozeh, Stiff, Pat, Meharchard, Jacinta, Schlossman, Robert, Brown, Randy, Tully, Heather, Benyunes, Mark, Jacobs, Cindy, Berenson, Ronald, DiPersio, John, Anderson, Ken, Berenson, James

“…High-dose chemotherapy followed by autologous transplantation has been shown to improve response rates and survival in multiple myeloma and other malignancies…”
Get full text